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Many bacteria pathogenic for plants or animals,
including Shigella spp., which is responsible for
shigellosis in humans, use a type III secretion
apparatus to inject effector proteins into host
cells. Effectors alter cell signaling and host re-
sponses induced upon infection; however, their
precise biochemical activities have been eluci-
dated in very few cases. Utilizing Saccharomy-
ces cerevisiae as a surrogate host, we show that
the Shigella effector IpaH9.8 interrupts phero-
mone response signaling by promoting the pro-
teasome-dependent destruction of the MAPKK
Ste7. In vitro, IpaH9.8 displayed ubiquitin ligase
activity toward ubiquitin and Ste7. Replace-
ment of a Cys residue that is invariant among
IpaH homologs of plant and animal pathogens
abolished the ubiquitin ligase activity of IpaH9.8.
We also present evidence that the IpaH
homolog SspH1 from Salmonella enterica can
ubiquitinate ubiquitin and PKN1, a previously
identified SspH1 interaction partner. This study
assigns a function for IpaH family members as
E3 ubiquitin ligases.
INTRODUCTION
Invading pathogens are sensed by host cells through sur-
veillance systems that initiate signaling cascades alerting
the immune system to the presence of pathogens. These
signaling cascades include both MAPK and nuclear fac-
tor-kB (NF-kB) programs that induce cytokine production
and ultimately result in inflammation (Inohara et al., 2005).
The regulated destruction of proteins via the ubiquitin
proteasome pathway governs many cellular processes,
including cell-cycle progression and signal transduction
pathways, such as the NF-kB pathway. Ubiquitination
involves one ubiquitin-activating enzyme (E1), a limited
number of ubiquitin-conjugating enzymes (E2s), and a
large number of ubiquitin-ligating enzymes (E3s). The C-
terminal Gly residue of ubiquitin is charged via a thioestherCelinkage onto a Cys residue of E1 and transferred to a Cys
residue of E2s. E3s recruit ubiquitinated E2s to specific
substrates that are ubiquitinated on Lys residues by an
amide linkage. RING and U box E3s promote the transfer
of ubiquitin from E2s to targets, whereas HECT domain
E3s transfer ubiquitin onto one of their Cys residues and
then to targets (Ardley and Robinson, 2005; Liu, 2004).
The ubiquitin moiety of ubiquitinated targets can then
be ubiquitinated on Lys residues 48 or 63 to produce poly-
ubiquitinated targets. Ubiquitin chains constructed by
Lys-48 linkages target proteins for destruction by the pro-
teasome, whereas those constructed by Lys-63 linkages
leads to altered protein function, such as the activation
of kinases (Liu, 2004).
Many gram-negative bacteria pathogenic for plants or
animals utilize a type III secretion (T3S) apparatus to inject
effector proteins into host cells (Galan and Cossart, 2005).
Bacteria of Shigella spp. cause shigellosis in humans by
invading the colonic mucosa. Their virulence is dependent
upon a 200 kb plasmid encoding a type III secretion (T3S)
system (Parsot, 2005). Shigella effector proteins that pro-
mote bacterial entry are produced and stored within the
bacterium at 37C and transit through the T3S apparatus
upon contact with epithelial cells (Menard et al., 1994). A
second wave of effectors, whose functions are unknown,
are produced only after contact with host cells (Demers
et al., 1998). These latter effectors include nine closely re-
lated IpaH proteins that are the effectors most abundantly
produced by Shigella (Demers et al., 1998). Expression of
these effectors is dependent upon an AraC family mem-
ber, MxiE, which activates transcription in response to
the activation of the T3S apparatus (Mavris et al., 2002;
Penno et al., 2005).
Defining the activity of T3S effectors is key to under-
standing pathogenesis; however, many effectors share
little sequence similarity with proteins of known function.
As T3S effectors are injected into cells, their targets are in-
tracellular. Yeasts have many proteins and processes well
conserved in higher eukaryotes and have been used to
gain clues to the role of effectors (reviewed in Valdivia,
2004). Recently, studies in yeast helped to elucidate the
function of the Shigella effectors IpgB1 and IpgB2 that act
as G protein mimics (Alto et al., 2006). To gain insight into
IpaH activity, we utilized Saccharomyces cerevisiae asll Host & Microbe 1, 77–83, March 2007 ª2007 Elsevier Inc. 77
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disrupts signaling through the pheromone response MAPK
pathway by promoting the proteasome-dependent degra-
dation of the MAPKK Ste7. In vitro assays were used to
demonstrate that effectors of the IpaH family, including
IpaH9.8 from Shigella and SspH1 from Salmonella, consti-
tute a novel class of E3 ubiquitin ligases.
RESULTS AND DISCUSSION
IpaH9.8 Inhibits the Pheromone Response MAPK
Pathway
To gain insight to IpaH9.8 activity, we utilized Saccharo-
myces cerevisiae as a surrogate model. Yeasts producing
FLAG-tagged IpaH9.8 under the control of the GAL pro-
moter were not impaired in their ability to grow at elevated
temperatures, in the presence of a variety of ions, or under
high and low osmotic stresses. Detection of mating pher-
omone by a G protein-coupled receptor activates an ar-
chetypal MAPK signaling cascade, inducing both arrest of
the cell cycle and transcription of mating genes (Figure 1A).
The pheromone a factor diffusing from a disk causes cell-
cycle arrest in MATa cells, resulting in a halo of inhibited
growth (Hoffman et al., 2002). Upon exposure to a factor,
wild-type yeast producing IpaH9.8 failed to form a halo
(Figure 1B) and to induce expression of a pheromone-re-
sponsive FUS1-lacZ reporter gene (Figure S1A in the Sup-
plemental Data available with this article online), indicating
that IpaH9.8 interferes with the pheromone response
pathway and acts on or upstream of the MAPK Fus3.
To identify the target of IpaH9.8, we used yeast strains
altered in the signaling cascade. Overproduction of the
G protein b subunit Ste4 activates the signaling pathway
and promotes growth arrest (Cole et al., 1990); production
of IpaH9.8 rescued this phenotype, i.e., allowed growth
(Figure S1B), indicating that IpaH9.8 acts downstream of
Ste4. The constitutively active variant of the MAPKKK
Ste11 encoded by the allele STE11-4 promotes elevated
transcription of pheromone-responsive genes, even in the
absence of pheromone (Stevenson et al., 1992). Growth of
the strain SY2625 harboring a FUS1-HIS3 pheromone-
inducible reporter is dependent on signaling through the
pheromone response pathway on a medium lacking histi-
dine and containing 3-amino triazole (Evangelista et al.,
1997). SY2625 containing a plasmid encoding Ste11-4,
but not those containing the vector, were His+ (Figure 1C),
consistent with activation of the pathway by Ste11-4 and
transcription of FUS1-HIS3. In contrast, yeasts containing
plasmids encoding Ste11-4 and IpaH9.8 were His
(Figure 1C), indicating that IpaH9.8 interrupts signaling
at or downstream of Ste11, on either the MAPK Fus3 or
the MAPKK Ste7 (Figure 1A). Immunoblot analysis indi-
cated that the amount of Ste7, but not of Ste11 and Fus3,
was drastically reduced in wild-type yeast producing
IpaH9.8, regardless of stimulation by a factor (Figure 1D
and data not shown). Upon phosphorylation by Ste11,
Ste7 is ubiquitinated and, following removal of ubiquitin
chains by the specific deubiquitinase Ubp3, is degraded
by the proteasome (Wang et al., 2003). In both ubp3D78 Cell Host & Microbe 1, 77–83, March 2007 ª2007 Elsevier Iand ste11D cells, production of IpaH9.8 still resulted in the
disappearance of Ste7 (Figure 1D and Figure S1C), indi-
cating that IpaH9.8-mediated disappearance of Ste7 is
independent of the known Ste7 degradation pathway.
Structure and Function of IpaH Family Members
Blockage of signaling downstream of Ste11 suggested
that IpaH9.8 should rescue sst2D cells defective for the
GTPase-activating protein encoded by SST2 (Figure 1A);
these cells are unable to dampen signaling and can not
grow in the presence of pheromone (Dohlman et al.,
1996). Indeed, production of IpaH9.8 allowed sst2D cells
to grow in the presence of pheromone (Figures 2A and
2B). IpaH7.8, another IpaH family member from Shigella,
also rescued the pheromone-induced growth arrest of
sst2D cells (Figure 2A), indicating that IpaH9.8 and
IpaH7.8 have similar activities in yeast.
The strong phenotype of sst2D cells producing IpaH
proteins was used to perform a functional analysis of IpaH
domains. The nine different IpaHs encoded by the viru-
lence plasmid and the chromosome (Yang et al., 2005)
Figure 1. IpaH9.8 Interrupts the Pheromone Response Path-
way by Targeting Ste7
(A) The pheromone response pathway and protein activities.
(B) Halo assays on glucose- or galactose-containing plates of wild-
type MATa yeast harboring either a vector or a plasmid encoding
IpaH9.8; the disk was impregnated with a factor.
(C) Growth on plates lacking His and containing 4 mM 3-amino triazole
and glucose or galactose of SY2625 yeast (FUS1-HIS3) harboring two
plasmids encoding (or not encoding, indicated as vector 1 and vector
2) Ste11-4 and IpaH9.8.
(D) Analysis using anti-Ste7, anti-Fus3, and anti-FLAG antibodies of
extracts of wild-type (WT) and ubp3D yeast producing IpaH9.8-
FLAG and exposed to a factor.nc.
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containing six to eight 20 residue leucine-rich repeats
(LRR) and an300 residue conserved C-terminal domain.
Production of neither IpaH9.8-Nter nor IpaH9.8-Cter
(Figure 2C) rescued growth of sst2D cells exposed to
pheromone (Figure 2A), indicating that both domains of
IpaH9.8 are required for the function in yeast.
Sequence comparisons revealed that the IpaH C-termi-
nal domain shares 25%–40% identity with two groups of
proteins of bacteria that contain a T3S system and are
pathogens of plants, fish, and mammals (Figure S2). One
group includes 18 600 residue proteins from Shigella
spp., Yersinia pestis (and Y. pseudotuberculosis), Salmo-
nella enterica, Edwardsiella ictaluri, Bradyrhizobium
japonica, and Rhizobium sp. strain NGR234, and the other
includes 15 1500 residue proteins from Pseudomonas
putida, P. entomophila, P. fluorescens, and P. syringae.
In both groups, the conserved domain is C terminal and
preceded by LRRs (Figure 2C).
Figure 2. Functional Analysis of IpaH Proteins in sst2D Yeast
and Domain Organization of IpaHs and Homologous Proteins
(A) Growth on glucose- or galactose-containing plates of serial dilu-
tions of sst2D yeast harboring plasmids encoding indicated proteins;
the lower panel shows plates containing a factor.
(B) Immunoblot analysis using anti-FLAG antibodies of extracts of
sst2D yeast producing indicated FLAG-tagged IpaH proteins.
(C) Schematic representation (not to scale) of S. flexneri IpaH9.8 and
IpaH7.8,S. entericaSspH1,P. putidaPP2212, andYersinia spp. YopM.
LRRs and conserved C-terminal domains are shown by open and solid
boxes, respectively, and residue positions are indicated by numbers.CellThe presence of one Cys residue among the nine resi-
dues that are identical in all members of the IpaH family
suggested that its thiol group might be involved in cataly-
sis. To test this hypothesis, Cys-337 of IpaH9.8 was
replaced by Ala in IpaH9.8-C337A. Although IpaH9.8-
C337A was produced in similar amounts to IpaH9.8
(Figure 2B), it did not allow sst2D cells to grow in the pres-
ence of pheromone (Figure 2A). Circular dichroism mea-
surements in the far-UV and near-UV regions on purified
GST-IpaH9.8 and GST-IpaH9.8-C337A showed that these
two proteins have similar secondary and tertiary structure
contents (Figure S3), suggesting that the Cys residue con-
served in all IpaH homologs is involved in function rather
than in structure.
IpaH-Mediated Disappearance of Ste7
Is Proteasome Dependent
To test if the IpaH-mediated disappearance of Ste7
required proteasome function, we used a yeast strain car-
rying the cim5-1 allele encoding a component of the 26-S
proteasome that is functional at 25C but not at 37C
(Ghislain et al., 1993). Ste7 was present in cim5-1 yeast
producing IpaH9.8-C337A at both temperatures and
IpaH9.8 at 37C but was not present in yeast producing
IpaH9.8 at 25C (Figure 3A). Moreover, the proteasome in-
hibitor MG132 prevented the disappearance of Ste7 pro-
voked by IpaH9.8 in a MG132-permeable erg6D mutant
(Lee and Goldberg, 1998) (data not shown). Thus, the dis-
appearance of Ste7 promoted by IpaH9.8 is proteasome
dependent.
IpaH9.8 Is an E3 Ubiquitin Ligase for Ste7
The observation that the degradation of Ste7 promoted by
IpaH9.8 is proteasome dependent led us to test in vitro if
IpaH9.8 might be involved in an ubiquitination pathway.
We found that the E2 enzyme UbcH5B was apparently
not ubiquitinated by E1 in the presence of GST-IpaH9.8
(Figure 3B). Furthermore, after ubiquitination of UbcH5B,
addition of GST-IpaH9.8 to the reaction mixture promoted
the removal of ubiquitin from UbcH5B (Figure 3B). This ac-
tivity was not observed when GST-IpaH9.8-C337A was
added to the reaction mixture (Figure 3B), indicating that
it required the Cys residue of IpaH9.8.
The amide linkage, but not the thioesther linkage, of
ubiquitin to ubiquitinated proteins is resistant to dithio-
threitol (DTT). In reactions containing IpaH9.8, but not in
those containing IpaH9.8-C337A or lacking UbcH5B, we
detected a DTT-resistant ubiquitinated protein of the
size of GST-IpaH9.8 (Figure S4). Since some E3 ubiquitin
ligases possess an autoubiquitination activity (Beaudenon
et al., 2005), these results suggested that IpaH9.8 might
be an E3 ubiquitin ligase.
Ubiquitin biotinylated on Lys residues can not support
polyubiquitination reactions. To test if IpaH9.8 could poly-
ubiquitinate proteins, reactions were performed using
HA-tagged ubiquitin, instead of biotinylated ubiquitin.
Anti-HA antibodies detected a ladder of ubiquitinated pro-
teins, from 24 to >200 kDa, in reactions performed in
the presence of GST-IpaH9.8, but not in the presence ofHost & Microbe 1, 77–83, March 2007 ª2007 Elsevier Inc. 79
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Ligase
(A) Immunoblot analysis using anti-FLAG,
anti-Ste7, and anti-Fus3 antibodies of extracts
of cim5-1 yeast producing FLAG-tagged
IpaH9.8-C337A (C337A) or IpaH9.8 at 25C or
37C.
(B) Immunoblot analysis using streptavidin-
peroxidase of reactions performed in the pres-
ence of biotinylated ubiquitin, E1, UbcH5B, and
either GST-IpaH9.8 (IpaH9.8) or GST-IpaH9.8-
C337A (C337A). For the sample loaded in lane
5, GST-IpaH9.8 was added after UbcH5B ubiq-
uitination, and the reaction mixture was further
incubated for 30 min.
(C) Immunoblot analysis using anti-HA and anti-
UbcH5 of reactions performed in the presence
of HA-ubiquitin, E1, UbcH5B, and either GST-
IpaH9.8 (IpaH9.8) or GST-IpaH9.8-C337A
(C337A).
(D) Immunoblot analysis using anti-Ste7, anti-
IpaH, and anti-Kss1 antibodies of reactions
performed in the presence of ubiquitin, E1,
UbcH5B, GST-IpaH9.8 (IpaH9.8), or GST-
IpaH9.8-C337A (C337A), as indicated, and a
complex containing Ste7, Ste11-4, and Kss1.
Samples were treated or not with DTT prior to
loading.GST-IpaH9.8-C337A (Figure 3C). Anti-UbcH5B anti-
bodies detected a single species corresponding to
UbcH5B (18 kDa), indicating that UbcH5B was not polyu-
biquitinated (Figure 3C). The sizes of species detected by
anti-HA antibodies were multiples of the size of HA-ubiq-
uitin (9 kDa), indicating that the molecule that was polyu-
biquitinated is ubiquitin. Using K48R and K63R ubiquitin
variants, we found that IpaH9.8 catalyzed the formation
of polyubiquitin chains on Lys-48, but not Lys-63 (data
not shown). We did not detect polyubiquitinated proteins
using the E2 UbcH7 (data not shown). These results dem-
onstrated that IpaH9.8 is endowed with ubiquitin ligase
activity toward ubiquitin and uses UbcH5B, but not
UbcH7, as an E2.
To test whether IpaH9.8 might ubiquitinate Ste7, puri-
fied active MAPK complexes containing Ste7, as well
as Ste11-4 and the MAPK Kss1, were incubated with na-
tive ubiquitin, E1, UbcH5B, and GST-IpaH9.8 or GST-
IpaH9.8-C337A. Both the non- and monoubiquitinated
forms of IpaH9.8 were detected using anti-IpaH anti-
bodies (Figure 3D), confirming the autoubiquitination ac-
tivity of IpaH9.8. In addition to Ste7, larger species that
formed only in the presence of IpaH9.8 were detected
by anti-Ste7 antibodies (Figure 3D). Thus, IpaH9.8 is an
E3 ubiquitin ligase for Ste7; the proteasome-dependent
disappearance of Ste7 in yeast was likely due to the deg-
radation of Ste7 following its polyubiquitination by IpaH9.8
and IpaH7.8.80 Cell Host & Microbe 1, 77–83, March 2007 ª2007 ElsevierThe IpaH Homolog SspH1 Is an E3 Ubiquitin
Ligase for PKN1
SspH1, one of the Salmonella enterica Typhimurium
homologs of IpaH, has been shown to interact with the
mammalian protein kinase PKN1 (Haraga and Miller,
2006). To test whether SspH1 shares activities with
IpaH9.8, we purified a GST-SspH1 recombinant protein.
As described above for IpaH9.8, SspH1 was endowed
with the activities (1) to remove ubiquitin from ubiquiti-
nated UbcH5B, (2) to autoubiquitinate, and (3) to polyubi-
quitinate HA-tagged ubiquitin (Figure 4). We also tested
ubiquitination of PKN1 by SspH1; SspH1, IpaH9.8, or
IpaH9.8-C337A was incubated with E1, native ubiquitin,
UbcH5B, and GST-PKN1. When the reaction was per-
formed in the presence of SspH1, anti-PKN1 antibodies
detected an additional species migrating at a size >250
kDa (Figure 4C). These results demonstrated that SspH1
is an E3 ubiquitin ligase that can use both ubiquitin and
PKN1 as substrates.
Concluding Remarks
We presented evidence that IpaH9.8 and SspH1 are E3
ubiquitin ligases, and we identified, in addition to ubiquitin,
a yeast substrate for IpaH9.8 (Ste7) and a mammalian
substrate for SspH1 (PKN1). Ubiquitin was apparently re-
moved from ubiquitinated UbcH5B upon incubation with
IpaH9.8 or SspH1; this latter activity corresponding to
the hydrolysis of the thioester bond linking ubiquitin toInc.
Cell Host & Microbe
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(A) Immunoblot analysis using streptavidin-peroxidase (streptavidin-PO) of reactions performed in the presence of biotinylated ubiquitin, E1,
UbcH5B, and either GST-IpaH9.8 (IpaH9.8), GST-IpaH9.8-C337A (C337A), or GST-SspH1 (SspH1). The two upper panels correspond to 15%
SDS-PAGE, and the two lower panels correspond to 8% SDS-PAGE. Samples were treated or not with DTT prior to loading, as indicated.
(B) Immunoblot analysis using anti-HA antibodies of reactions performed in the presence of HA-ubiquitin, E1, UbcH5B, and either GST-IpaH9.8
(IpaH9.8), GST-IpaH9.8-C337A (C337A), or GST-SspH1 (SspH1).
(C) Immunoblot analysis using anti-PKN1 and anti-GST antibodies of reactions performed in the presence of ubiquitin, E1, UbcH5B, GST-PKN1
(PKN1), and either GST-IpaH9.8 (IpaH9.8), GST-IpaH9.8-C337A (C337A), or GST-SspH1 (SspH1).the E2 is not equivalent to the activity of deubiquitinating
enzymes hydrolyzing the amide bond linking ubiquitin to
target proteins (Amerik and Hochstrasser, 2004). It might
correspond either to the total consumption of the ubiquiti-
nated E2 by the polyubiquitination activity of IpaH9.8 and
SspH1 toward ubiquitin or to the transfer of ubiquitin onto
IpaH9.8 and SspH1 prior to its transfer onto the substrate,
as described for HECT domain E3s (Ardley and Robinson,
2005; Scheffner et al., 1995). Although the latter hypothe-
sis is consistent with the observation that the Cys residue
conserved in all IpaH family members is required for
IpaH9.8 activities both in yeast and in vitro, we could not
detect ubiquitin-IpaH9.8 and ubiquitin-SspH1 intermedi-
ates. The HECT domain of E3s and the C-terminal domain
of IpaH proteins do not share sequence similarities; fur-
thermore, residues surrounding the catalytic Cys residue
in HECT domain E3s and the conserved Cys residue in
IpaH proteins are different. Accordingly, IpaH family mem-
bers constitute a novel class of E3 ubiquitin ligases.
Co-opting the ubiquitination pathway, either to promote
or prevent ubiquitination of host proteins, is emerging as a
common strategy employed by pathogens using T3S sys-
tems to downregulate host responses. The effector AvrP-
toB from the tomato pathogen P. syringae is structurally
similar to U box and RING finger E3s, possesses autoubi-
quitination and presumably ubiquitin ligase activities to-
ward host proteins, and blocks signaling cascades that
limit infection by activating the cell death program (Abra-Cemovitch et al., 2006; Janjusevic et al., 2006). Through an
unknown mechanism, the P. syringae effector HopM1
promotes the proteasome-dependent degradation of the
Arabidopsis protein AtMIN7 and inhibits vesicle trafficking
required to mount a cell-wall-based defense to infection
(Nomura et al., 2006). The Salmonella effector SopA has
recently been shown to be a HECT-like E3 endowed
with an autoubiquitination activity (Zhang et al., 2006).
The Shigella effector OspG, encoded in the same operon
as ipaH9.8, is a kinase that binds ubiquitinated E2s, pre-
vents ubiquitination of phospho-IkBa, and dampens in-
flammation in the host (Kim et al., 2005). As shown here,
the Salmonella effector SspH1 is an E3 ubiquitin ligase
for PKN1, a protein kinase involved in the NF-kB pathway
and activated upon cell infection (Haraga and Miller,
2006). The S. flexneri chromosomally encoded IpaH
proteins have been reported to play a role in dampening
inflammation (Ashida et al., 2007). The LRR-containing
N-terminal domain of IpaHs is likely involved in protein-
protein interactions and substrate recognition; the Yersi-
nia effector YopM containing only LRRs related to those
of IpaHs (Figure 2C) can act as a scaffolding protein that
brings host kinases together (McDonald et al., 2003);
and the LRR domain of SspH1 interacts with PKN1 (Har-
aga and Miller, 2006). In HeLa cells infected by S. flexneri
for 90 min, we did not observe a significant decrease in the
amount of the MAPKK Mek1, Mek3, and IKKa (Figure S5),
suggesting that these proteins are not degraded uponll Host & Microbe 1, 77–83, March 2007 ª2007 Elsevier Inc. 81
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in human cells remain to be identified.
The demonstration that IpaH9.8 and SspH1 are E3
ubiquitin ligases paves the way toward understanding
the function of these proteins and their homologs during
infection by identifying their target(s), possibly protein
kinases, in host cells. Shigella produces multiple IpaHs
that differ in their LRR domain, and likewise, some other
pathogens contain several genes encoding IpaH homo-
logs. This diversity suggests that each of these pathogens
uses a repertoire of E3 ubiquitin ligases to promote degra-
dation of several host proteins.
EXPERIMENTAL PROCEDURES
Materials
Plasmids encoding FLAG-tagged IpaH9.8, IpaH9.8-C337A, IpaH9.8-
Cter, IpaH9.8-Nter, and IpaH7.8 were derivatives of the vector
pFL38CII/pGal1 containing the GAL promoter (Badis et al., 2004).
YCp50-STE11-4 carrying STE11-4 under the control of its own pro-
moter and pRS316-GAL-STE4 carrying STE4 under the control of the
GAL promoter have been described (Dohlman et al., 1995; Stevenson
et al., 1992). Yeast strains are described in Table S1. UbcH7, E1, ubiq-
uitin, HA-ubiquitin, biotinylated ubiquitin, ubiquitin-K48R and -K63R,
horseradish peroxidase-coupled avidin, MG132, and anti-UbcH5
antibodies were purchased from Boston Biochem. Anti-IkBa, -ubiqui-
tin, -Ste7, -Fus3, -Mek3, -IKKa, -Kss1, and -PKN1 antibodies were pur-
chased from Santa Cruz Biotechnology. Purified GST-PKN1 was pur-
chased from Invitrogen. Anti-Mek1 antibodies and purified active
Mek1 were purchased from Upstate Cell Signaling Solutions. The mat-
ing pheromone a factor was purchased from Sigma. His-tagged
UbcH5B was prepared as described (Kim et al., 2005). GST-IpaH9.8,
GST-IpaH9.8-C337A, and GST-SspH1 were prepared as described
(Mavris et al., 2002). Complexes containing Ste11-4, Ste7, and Kss1
were prepared as described (Breitkreutz et al., 2001) and eluted from
FLAG M2-agarose affinity gel (Sigma) using a FLAG peptide.
In Vitro Assays
Ubiquitination of UbcH5B-His by E1 was performed in a 40 ml reaction
mixture containing buffer A (25 mM Tris$HCl [pH 7.5], 50 mM NaCl,
5 mM ATP, 10 mM MgCl2, 0.1 mM DTT), 2 mg of biotinylated ubiquitin,
0.5 mg of E1, and 2 mg of E2 in the presence or absence of 1 mg of
GST-IpaH9.8, GST-IpaH9.8-C337A, or GST-SspH1. Reactions were
incubated at 37C for 1 hr and stopped by the addition of an equal vol-
ume of Laemmli sample buffer (62.5 mM Tris-Hcl [pH 6.8], 10% glyc-
erol, 2% SDS, 0.0005% bromophenol blue) containing or not contain-
ing 100 mM DTT. Ubiquitination reactions were carried out in the same
manner except that 2 mg of HA-tagged ubiquitin, ubiquitin, or ubiquitin-
48R or -3R were used instead of biotinylated ubiquitin. Approximately
1 mg of Ste11-4:Ste7:Kss1 complexes, or 0.4 mg of GST-PKN1, was in-
cubated in buffer A with 5 mg of ubiquitin, 0.5 mg of E1, and 2 mg of E2 in
the presence or absence of 0.6 mg of GST-IpaH9.8, GST-IpaH9.8-
C337A, or GST-SspH1. Reaction mixtures were separated by SDS/
PAGE, transferred onto a nitrocellulose membrane, and probed with
specific antibodies or peroxidase-coupled streptavidin when biotiny-
lated ubiquitin was used.
Supplemental Data
The Supplemental Data include Supplemental Experimental Proce-
dures, five supplemental figures, and one supplemental table and can
be found with this article online at http://www.cellhostandmicrobe.
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